Review



complement c3 protein  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    MedChemExpress complement c3 protein
    Complement C3 Protein, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 11 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/complement c3 protein/product/MedChemExpress
    Average 93 stars, based on 11 article reviews
    complement c3 protein - by Bioz Stars, 2026-04
    93/100 stars

    Images



    Similar Products

    93
    MedChemExpress complement c3 protein
    Complement C3 Protein, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/complement c3 protein/product/MedChemExpress
    Average 93 stars, based on 1 article reviews
    complement c3 protein - by Bioz Stars, 2026-04
    93/100 stars
      Buy from Supplier

    93
    R&D Systems human recombinant c3a
    Human Recombinant C3a, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human recombinant c3a/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    human recombinant c3a - by Bioz Stars, 2026-04
    93/100 stars
      Buy from Supplier

    93
    MedChemExpress recombinant mouse c3 c3a protein
    Recombinant Mouse C3 C3a Protein, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant mouse c3 c3a protein/product/MedChemExpress
    Average 93 stars, based on 1 article reviews
    recombinant mouse c3 c3a protein - by Bioz Stars, 2026-04
    93/100 stars
      Buy from Supplier

    93
    R&D Systems recombinant mouse c3a
    Time-dependent <t>complement</t> <t>activation</t> and anaphylatoxin receptor expression in ALI cultures exposed to HDM. ( a ) C3 and <t>C3a</t> concentrations in cell lysates and the SN of unstimulated (steady-state) ALI cultures and 24, 48 and 72 h after HDM exposure (steady-state, 24, 48 and 72 h: n = 6). * p < 0.05; ** p < 0.01; *** p < 0.001. ( b ) HDM and HI-HDM mediated cleavage of hC3 into hC3a ( n = 3 independent experiments). Data are shown as mean ± SEM. Data were analyzed using an unpaired T -test. *** p < 0.001. ( c ) C5 and C5a concentrations in cell lysates and the SN of steady-state ALI cultures and 24, 48 and 72 h after HDM exposure. Data are shown as mean ± SEM (steady-state, 24, 48 and 72 h: n = 6). ( d ) Comparison of C3 and C5 ( left panel ), C3a and C5a ( right panel ) concentrations in cell lysates from steady-state ALI cultures and 24, 48 and 72 h after HDM exposure. Data are shown as mean ± SEM (steady-state, 24, 48 and 72 h: n = 6). Data were analyzed using two-way ANOVA with Šidák’s multiple comparisons test. **** p < 0.0001. ( e ) Immunofluorescence analysis of C3aR and C5aR1 expression in unstimulated ALI cultures and 24, 48 and 72 h after HDM exposure. Data are shown as mean ± SEM ( n = 3). Data were analyzed using one-way ANOVA with Holm–Šidák’s multiple comparisons test. * p < 0.05; ** p < 0.01. The number of experiments shown in ( a , c – e ) refers to biological replicates derived from 6 independent preparations of trachea, each representing a separate cell isolation and culture.
    Recombinant Mouse C3a, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant mouse c3a/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    recombinant mouse c3a - by Bioz Stars, 2026-04
    93/100 stars
      Buy from Supplier

    93
    R&D Systems c3a
    ( A ) The blood coagulation cascade, highlighting molecules whose levels in urine are significantly correlated with renal pathology AI (blue font), CI (CI) (red font), or both (purple font) in LN. Other proteins are listed in black font (interrogated but not significantly changed) or grey font (not interrogated by the proteomic screen). Uninterrupted arrows indicate activation, and interrupted arrows signify inhibition or cleavage of downstream protein or substrate. The yellow bubbles highlight only proteins significantly elevated in LN with high-CI versus low-CI (FC ≥ 2; P < 0.05) or higher in CI than in AI by at least 10%. The pink bubbles highlight proteins whose levels were significantly elevated only in patients with LN with high-AI versus low-AI (FC ≥ 2; P < 0.05) or higher in AI than in CI by at least 10% (in terms of correlation coefficient or FC). Also shown is a Spearman correlation heatmap displaying correlations among the 27 coagulation-related proteins and renal pathology metrics. * P < 0.05, ** P < 0.01, *** P < 0.001, and **** P < 0.0001. ( B ) The <t>complement</t> <t>activation</t> pathway highlighting molecules whose levels in urine are significantly elevated with AI, CI, or both. See A for other annotation details. Also shown is a Spearman correlation heatmap displaying correlations among the 32 complement related proteins and their paired renal pathology metrics, as detailed in A . α2-AP, MG, α2-antiplasmin, α2-macroglobulin; APC, activated protein C; AT, antithrombin; B, factor B; BK, bradykinin; C1 INH, C1 esterase inhibitor; C4BP, C4 binding protein; CL-K1, collectin kidney 1; D, factor D; DAF, decay-accelerating factor; FDP, fibrin degradation products; H, factor H; I, factor I; MAP-1, MBL/ficolin-associated protein 1; MASP, mannan-binding lectin-associated serine protease; MBL, mannose-binding lectin; MCP, membrane cofactor protein; P, properdin; PK, prekallikrein; sMAP, small MBL-associated protein; TM, thrombomodulin; tPA, tissue plasminogen activator; uPA, urokinase.
    C3a, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/c3a/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    c3a - by Bioz Stars, 2026-04
    93/100 stars
      Buy from Supplier

    96
    Quidel complement proteins c3a
    ( A ) The blood coagulation cascade, highlighting molecules whose levels in urine are significantly correlated with renal pathology AI (blue font), CI (CI) (red font), or both (purple font) in LN. Other proteins are listed in black font (interrogated but not significantly changed) or grey font (not interrogated by the proteomic screen). Uninterrupted arrows indicate activation, and interrupted arrows signify inhibition or cleavage of downstream protein or substrate. The yellow bubbles highlight only proteins significantly elevated in LN with high-CI versus low-CI (FC ≥ 2; P < 0.05) or higher in CI than in AI by at least 10%. The pink bubbles highlight proteins whose levels were significantly elevated only in patients with LN with high-AI versus low-AI (FC ≥ 2; P < 0.05) or higher in AI than in CI by at least 10% (in terms of correlation coefficient or FC). Also shown is a Spearman correlation heatmap displaying correlations among the 27 coagulation-related proteins and renal pathology metrics. * P < 0.05, ** P < 0.01, *** P < 0.001, and **** P < 0.0001. ( B ) The <t>complement</t> <t>activation</t> pathway highlighting molecules whose levels in urine are significantly elevated with AI, CI, or both. See A for other annotation details. Also shown is a Spearman correlation heatmap displaying correlations among the 32 complement related proteins and their paired renal pathology metrics, as detailed in A . α2-AP, MG, α2-antiplasmin, α2-macroglobulin; APC, activated protein C; AT, antithrombin; B, factor B; BK, bradykinin; C1 INH, C1 esterase inhibitor; C4BP, C4 binding protein; CL-K1, collectin kidney 1; D, factor D; DAF, decay-accelerating factor; FDP, fibrin degradation products; H, factor H; I, factor I; MAP-1, MBL/ficolin-associated protein 1; MASP, mannan-binding lectin-associated serine protease; MBL, mannose-binding lectin; MCP, membrane cofactor protein; P, properdin; PK, prekallikrein; sMAP, small MBL-associated protein; TM, thrombomodulin; tPA, tissue plasminogen activator; uPA, urokinase.
    Complement Proteins C3a, supplied by Quidel, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/complement proteins c3a/product/Quidel
    Average 96 stars, based on 1 article reviews
    complement proteins c3a - by Bioz Stars, 2026-04
    96/100 stars
      Buy from Supplier

    93
    MedChemExpress complement c3a protein
    ( A ) The blood coagulation cascade, highlighting molecules whose levels in urine are significantly correlated with renal pathology AI (blue font), CI (CI) (red font), or both (purple font) in LN. Other proteins are listed in black font (interrogated but not significantly changed) or grey font (not interrogated by the proteomic screen). Uninterrupted arrows indicate activation, and interrupted arrows signify inhibition or cleavage of downstream protein or substrate. The yellow bubbles highlight only proteins significantly elevated in LN with high-CI versus low-CI (FC ≥ 2; P < 0.05) or higher in CI than in AI by at least 10%. The pink bubbles highlight proteins whose levels were significantly elevated only in patients with LN with high-AI versus low-AI (FC ≥ 2; P < 0.05) or higher in AI than in CI by at least 10% (in terms of correlation coefficient or FC). Also shown is a Spearman correlation heatmap displaying correlations among the 27 coagulation-related proteins and renal pathology metrics. * P < 0.05, ** P < 0.01, *** P < 0.001, and **** P < 0.0001. ( B ) The <t>complement</t> <t>activation</t> pathway highlighting molecules whose levels in urine are significantly elevated with AI, CI, or both. See A for other annotation details. Also shown is a Spearman correlation heatmap displaying correlations among the 32 complement related proteins and their paired renal pathology metrics, as detailed in A . α2-AP, MG, α2-antiplasmin, α2-macroglobulin; APC, activated protein C; AT, antithrombin; B, factor B; BK, bradykinin; C1 INH, C1 esterase inhibitor; C4BP, C4 binding protein; CL-K1, collectin kidney 1; D, factor D; DAF, decay-accelerating factor; FDP, fibrin degradation products; H, factor H; I, factor I; MAP-1, MBL/ficolin-associated protein 1; MASP, mannan-binding lectin-associated serine protease; MBL, mannose-binding lectin; MCP, membrane cofactor protein; P, properdin; PK, prekallikrein; sMAP, small MBL-associated protein; TM, thrombomodulin; tPA, tissue plasminogen activator; uPA, urokinase.
    Complement C3a Protein, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/complement c3a protein/product/MedChemExpress
    Average 93 stars, based on 1 article reviews
    complement c3a protein - by Bioz Stars, 2026-04
    93/100 stars
      Buy from Supplier

    94
    MedChemExpress recombinant mouse c3a protein absin abs04528 complement c3 c3a
    ( A ) The blood coagulation cascade, highlighting molecules whose levels in urine are significantly correlated with renal pathology AI (blue font), CI (CI) (red font), or both (purple font) in LN. Other proteins are listed in black font (interrogated but not significantly changed) or grey font (not interrogated by the proteomic screen). Uninterrupted arrows indicate activation, and interrupted arrows signify inhibition or cleavage of downstream protein or substrate. The yellow bubbles highlight only proteins significantly elevated in LN with high-CI versus low-CI (FC ≥ 2; P < 0.05) or higher in CI than in AI by at least 10%. The pink bubbles highlight proteins whose levels were significantly elevated only in patients with LN with high-AI versus low-AI (FC ≥ 2; P < 0.05) or higher in AI than in CI by at least 10% (in terms of correlation coefficient or FC). Also shown is a Spearman correlation heatmap displaying correlations among the 27 coagulation-related proteins and renal pathology metrics. * P < 0.05, ** P < 0.01, *** P < 0.001, and **** P < 0.0001. ( B ) The <t>complement</t> <t>activation</t> pathway highlighting molecules whose levels in urine are significantly elevated with AI, CI, or both. See A for other annotation details. Also shown is a Spearman correlation heatmap displaying correlations among the 32 complement related proteins and their paired renal pathology metrics, as detailed in A . α2-AP, MG, α2-antiplasmin, α2-macroglobulin; APC, activated protein C; AT, antithrombin; B, factor B; BK, bradykinin; C1 INH, C1 esterase inhibitor; C4BP, C4 binding protein; CL-K1, collectin kidney 1; D, factor D; DAF, decay-accelerating factor; FDP, fibrin degradation products; H, factor H; I, factor I; MAP-1, MBL/ficolin-associated protein 1; MASP, mannan-binding lectin-associated serine protease; MBL, mannose-binding lectin; MCP, membrane cofactor protein; P, properdin; PK, prekallikrein; sMAP, small MBL-associated protein; TM, thrombomodulin; tPA, tissue plasminogen activator; uPA, urokinase.
    Recombinant Mouse C3a Protein Absin Abs04528 Complement C3 C3a, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant mouse c3a protein absin abs04528 complement c3 c3a/product/MedChemExpress
    Average 94 stars, based on 1 article reviews
    recombinant mouse c3a protein absin abs04528 complement c3 c3a - by Bioz Stars, 2026-04
    94/100 stars
      Buy from Supplier

    Image Search Results


    Time-dependent complement activation and anaphylatoxin receptor expression in ALI cultures exposed to HDM. ( a ) C3 and C3a concentrations in cell lysates and the SN of unstimulated (steady-state) ALI cultures and 24, 48 and 72 h after HDM exposure (steady-state, 24, 48 and 72 h: n = 6). * p < 0.05; ** p < 0.01; *** p < 0.001. ( b ) HDM and HI-HDM mediated cleavage of hC3 into hC3a ( n = 3 independent experiments). Data are shown as mean ± SEM. Data were analyzed using an unpaired T -test. *** p < 0.001. ( c ) C5 and C5a concentrations in cell lysates and the SN of steady-state ALI cultures and 24, 48 and 72 h after HDM exposure. Data are shown as mean ± SEM (steady-state, 24, 48 and 72 h: n = 6). ( d ) Comparison of C3 and C5 ( left panel ), C3a and C5a ( right panel ) concentrations in cell lysates from steady-state ALI cultures and 24, 48 and 72 h after HDM exposure. Data are shown as mean ± SEM (steady-state, 24, 48 and 72 h: n = 6). Data were analyzed using two-way ANOVA with Šidák’s multiple comparisons test. **** p < 0.0001. ( e ) Immunofluorescence analysis of C3aR and C5aR1 expression in unstimulated ALI cultures and 24, 48 and 72 h after HDM exposure. Data are shown as mean ± SEM ( n = 3). Data were analyzed using one-way ANOVA with Holm–Šidák’s multiple comparisons test. * p < 0.05; ** p < 0.01. The number of experiments shown in ( a , c – e ) refers to biological replicates derived from 6 independent preparations of trachea, each representing a separate cell isolation and culture.

    Journal: Cells

    Article Title: House Dust Mite Nebulization Drives Alarmin and Complement Activation in a Murine Tracheal Air–Liquid Interface Culture System

    doi: 10.3390/cells14201598

    Figure Lengend Snippet: Time-dependent complement activation and anaphylatoxin receptor expression in ALI cultures exposed to HDM. ( a ) C3 and C3a concentrations in cell lysates and the SN of unstimulated (steady-state) ALI cultures and 24, 48 and 72 h after HDM exposure (steady-state, 24, 48 and 72 h: n = 6). * p < 0.05; ** p < 0.01; *** p < 0.001. ( b ) HDM and HI-HDM mediated cleavage of hC3 into hC3a ( n = 3 independent experiments). Data are shown as mean ± SEM. Data were analyzed using an unpaired T -test. *** p < 0.001. ( c ) C5 and C5a concentrations in cell lysates and the SN of steady-state ALI cultures and 24, 48 and 72 h after HDM exposure. Data are shown as mean ± SEM (steady-state, 24, 48 and 72 h: n = 6). ( d ) Comparison of C3 and C5 ( left panel ), C3a and C5a ( right panel ) concentrations in cell lysates from steady-state ALI cultures and 24, 48 and 72 h after HDM exposure. Data are shown as mean ± SEM (steady-state, 24, 48 and 72 h: n = 6). Data were analyzed using two-way ANOVA with Šidák’s multiple comparisons test. **** p < 0.0001. ( e ) Immunofluorescence analysis of C3aR and C5aR1 expression in unstimulated ALI cultures and 24, 48 and 72 h after HDM exposure. Data are shown as mean ± SEM ( n = 3). Data were analyzed using one-way ANOVA with Holm–Šidák’s multiple comparisons test. * p < 0.05; ** p < 0.01. The number of experiments shown in ( a , c – e ) refers to biological replicates derived from 6 independent preparations of trachea, each representing a separate cell isolation and culture.

    Article Snippet: Plates were washed four times with 0.05% Tween 20 in PBS; serial dilutions of recombinant mouse C3a (R&D Systems #8085-C3-025—Minneapolis, MN, USA) were performed; and samples were added (25 μL/well) and incubated at RT for 90 min. After washing four times with 0.05% Tween 20 in PBS, 25 μL/well of 1 μg/mL in 1% BSA/PBS biotinylated anti-mouse C3a detection antibody (clone I87-419, BD Biosciences #558251—San Jose, CA, USA) was added and incubated for 1 h at RT.

    Techniques: Activation Assay, Expressing, Comparison, Immunofluorescence, Derivative Assay, Cell Isolation

    ( A ) The blood coagulation cascade, highlighting molecules whose levels in urine are significantly correlated with renal pathology AI (blue font), CI (CI) (red font), or both (purple font) in LN. Other proteins are listed in black font (interrogated but not significantly changed) or grey font (not interrogated by the proteomic screen). Uninterrupted arrows indicate activation, and interrupted arrows signify inhibition or cleavage of downstream protein or substrate. The yellow bubbles highlight only proteins significantly elevated in LN with high-CI versus low-CI (FC ≥ 2; P < 0.05) or higher in CI than in AI by at least 10%. The pink bubbles highlight proteins whose levels were significantly elevated only in patients with LN with high-AI versus low-AI (FC ≥ 2; P < 0.05) or higher in AI than in CI by at least 10% (in terms of correlation coefficient or FC). Also shown is a Spearman correlation heatmap displaying correlations among the 27 coagulation-related proteins and renal pathology metrics. * P < 0.05, ** P < 0.01, *** P < 0.001, and **** P < 0.0001. ( B ) The complement activation pathway highlighting molecules whose levels in urine are significantly elevated with AI, CI, or both. See A for other annotation details. Also shown is a Spearman correlation heatmap displaying correlations among the 32 complement related proteins and their paired renal pathology metrics, as detailed in A . α2-AP, MG, α2-antiplasmin, α2-macroglobulin; APC, activated protein C; AT, antithrombin; B, factor B; BK, bradykinin; C1 INH, C1 esterase inhibitor; C4BP, C4 binding protein; CL-K1, collectin kidney 1; D, factor D; DAF, decay-accelerating factor; FDP, fibrin degradation products; H, factor H; I, factor I; MAP-1, MBL/ficolin-associated protein 1; MASP, mannan-binding lectin-associated serine protease; MBL, mannose-binding lectin; MCP, membrane cofactor protein; P, properdin; PK, prekallikrein; sMAP, small MBL-associated protein; TM, thrombomodulin; tPA, tissue plasminogen activator; uPA, urokinase.

    Journal: The Journal of Clinical Investigation

    Article Title: Urine proteins reveal distinct coagulation and complement cascades underlying acute versus chronic lupus nephritis

    doi: 10.1172/JCI186143

    Figure Lengend Snippet: ( A ) The blood coagulation cascade, highlighting molecules whose levels in urine are significantly correlated with renal pathology AI (blue font), CI (CI) (red font), or both (purple font) in LN. Other proteins are listed in black font (interrogated but not significantly changed) or grey font (not interrogated by the proteomic screen). Uninterrupted arrows indicate activation, and interrupted arrows signify inhibition or cleavage of downstream protein or substrate. The yellow bubbles highlight only proteins significantly elevated in LN with high-CI versus low-CI (FC ≥ 2; P < 0.05) or higher in CI than in AI by at least 10%. The pink bubbles highlight proteins whose levels were significantly elevated only in patients with LN with high-AI versus low-AI (FC ≥ 2; P < 0.05) or higher in AI than in CI by at least 10% (in terms of correlation coefficient or FC). Also shown is a Spearman correlation heatmap displaying correlations among the 27 coagulation-related proteins and renal pathology metrics. * P < 0.05, ** P < 0.01, *** P < 0.001, and **** P < 0.0001. ( B ) The complement activation pathway highlighting molecules whose levels in urine are significantly elevated with AI, CI, or both. See A for other annotation details. Also shown is a Spearman correlation heatmap displaying correlations among the 32 complement related proteins and their paired renal pathology metrics, as detailed in A . α2-AP, MG, α2-antiplasmin, α2-macroglobulin; APC, activated protein C; AT, antithrombin; B, factor B; BK, bradykinin; C1 INH, C1 esterase inhibitor; C4BP, C4 binding protein; CL-K1, collectin kidney 1; D, factor D; DAF, decay-accelerating factor; FDP, fibrin degradation products; H, factor H; I, factor I; MAP-1, MBL/ficolin-associated protein 1; MASP, mannan-binding lectin-associated serine protease; MBL, mannose-binding lectin; MCP, membrane cofactor protein; P, properdin; PK, prekallikrein; sMAP, small MBL-associated protein; TM, thrombomodulin; tPA, tissue plasminogen activator; uPA, urokinase.

    Article Snippet: After 3 days of differentiation, the medium was replaced with serum-free medium for 24 hours, after which the cells were treated for 72 hours with either vehicle or 10 ng/mL C3a (R&D Systems 3677-C3-025) or 10 ng/mL of C5a (R&D Systems 2037-C5-025/CF).

    Techniques: Coagulation, Activation Assay, Inhibition, Binding Assay, Membrane

    ( A ) Shown are representative fields from 3 independent experiments. Complement proteins C3a and C5a increased the expression of ECM proteins in THP1 macrophages, BMDMs, and HK2 proximal tubule cells after 72 hours of treatment in serum-free medium. Scale bars: 50 μm. ( B – D ) The scatter plots show the mean staining intensity per THP-1 macrophage ( B ), BMDM ( C ), and HK2 proximal tubule cell ( D ), normalized to expression levels in their respective vehicle-treated groups. Each data point corresponds to quantified fluorescence intensity in a single field of view (FOV) from the microscope, and the larger dots represent the average of FOVs in biological replicates, each of which is color coded. RT-qPCR analysis of ECM protein coding genes were measured in BMDMs ( E ) and in HK2 proximal tubule cells ( F ). Gene expression was normalized to the expression of 18S ribosomal RNA in the same sample and then normalized to the expression level of vehicle-treated group ( n = 4). * P < 0.05, ** P < 0.01, and *** P < 0.001 by 2-tailed Student’s t test.

    Journal: The Journal of Clinical Investigation

    Article Title: Urine proteins reveal distinct coagulation and complement cascades underlying acute versus chronic lupus nephritis

    doi: 10.1172/JCI186143

    Figure Lengend Snippet: ( A ) Shown are representative fields from 3 independent experiments. Complement proteins C3a and C5a increased the expression of ECM proteins in THP1 macrophages, BMDMs, and HK2 proximal tubule cells after 72 hours of treatment in serum-free medium. Scale bars: 50 μm. ( B – D ) The scatter plots show the mean staining intensity per THP-1 macrophage ( B ), BMDM ( C ), and HK2 proximal tubule cell ( D ), normalized to expression levels in their respective vehicle-treated groups. Each data point corresponds to quantified fluorescence intensity in a single field of view (FOV) from the microscope, and the larger dots represent the average of FOVs in biological replicates, each of which is color coded. RT-qPCR analysis of ECM protein coding genes were measured in BMDMs ( E ) and in HK2 proximal tubule cells ( F ). Gene expression was normalized to the expression of 18S ribosomal RNA in the same sample and then normalized to the expression level of vehicle-treated group ( n = 4). * P < 0.05, ** P < 0.01, and *** P < 0.001 by 2-tailed Student’s t test.

    Article Snippet: After 3 days of differentiation, the medium was replaced with serum-free medium for 24 hours, after which the cells were treated for 72 hours with either vehicle or 10 ng/mL C3a (R&D Systems 3677-C3-025) or 10 ng/mL of C5a (R&D Systems 2037-C5-025/CF).

    Techniques: Expressing, Staining, Fluorescence, Microscopy, Quantitative RT-PCR, Gene Expression

    Circulating immune complexes and Abs planted directly within glomerular and tubulo-interstitial regions of the kidneys may fix complement, resulting in complement activation. The alternative pathway may further amplify complement activation within the kidneys. The products of C3 and C5 convertases, including the anaphylatoxins C3a and C5a, engage cognate receptors on a wide spectrum of immune cells, leading to immune cell activation, release of cytokines and chemokines, and acute inflammation, leading to high AI, as depicted on the left. Long-standing, unresolved complement activation and eventual formation of MAC may additionally engage and activate more immune and renal-resident cells, leading to tissue damage and repair, ECM deposition, and renal fibrosis, leading to high CI, as depicted on the right.

    Journal: The Journal of Clinical Investigation

    Article Title: Urine proteins reveal distinct coagulation and complement cascades underlying acute versus chronic lupus nephritis

    doi: 10.1172/JCI186143

    Figure Lengend Snippet: Circulating immune complexes and Abs planted directly within glomerular and tubulo-interstitial regions of the kidneys may fix complement, resulting in complement activation. The alternative pathway may further amplify complement activation within the kidneys. The products of C3 and C5 convertases, including the anaphylatoxins C3a and C5a, engage cognate receptors on a wide spectrum of immune cells, leading to immune cell activation, release of cytokines and chemokines, and acute inflammation, leading to high AI, as depicted on the left. Long-standing, unresolved complement activation and eventual formation of MAC may additionally engage and activate more immune and renal-resident cells, leading to tissue damage and repair, ECM deposition, and renal fibrosis, leading to high CI, as depicted on the right.

    Article Snippet: After 3 days of differentiation, the medium was replaced with serum-free medium for 24 hours, after which the cells were treated for 72 hours with either vehicle or 10 ng/mL C3a (R&D Systems 3677-C3-025) or 10 ng/mL of C5a (R&D Systems 2037-C5-025/CF).

    Techniques: Activation Assay